Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.
Year: 2003
Type: article
Source: PubMed
Authors: Jean S Beebe, Jitesh P Jani, Elisabeth Knauth, Peter Goodwin, Carla Higdon, Ann Marie Rossi, Erling Emerson, Martin Finkelstein, Eugenia Floyd, Shawn Harriman, Jim Atherton, Steve Hillerman, Cathy Soderstrom, Kou Kou, Tom Gant, Mark C Noe, Barb Foster, Farzan Rastinejad, Matthew A Marx, Tracey Schaeffer, Pamela M Whalen, W Gregory Roberts
Institution: Pfizer (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1903450321